心房颤动抗凝药物的最新研究进展

罗文榕, 赵志敬. 心房颤动抗凝药物的最新研究进展[J]. 心脏杂志, 2016, 28(6): 731-735.

引用本文:

罗文榕, 赵志敬. 心房颤动抗凝药物的最新研究进展[J]. 心脏杂志, 2016, 28(6): 731-735.

Research progress of anticoagulants in atrial fibrillation[J]. Chinese Heart Journal, 2016, 28(6): 731-735.

Citation:

Research progress of anticoagulants in atrial fibrillation[J]. Chinese Heart Journal, 2016, 28(6): 731-735.

Research progress of anticoagulants in atrial fibrillation

摘要: 大部分心房颤动（AF）患者都需要接受抗凝治疗，2014年美国心脏学会更新的AF抗凝指南将新型口服靶向抗凝药划入选择的范畴。本文就AF抗凝药物的最新研究进展作一介绍。

Abstract: Most patients with atrial fibrillation (AF) will be treated with anticoagulants. In 2004, the American Heart Association updated the anticoagulant guidelines for AF and classified the target-specific oral anticoagulants as a new alternative. This review is to introduce the latest research progress of anticoagulants in AF.

/